Literature DB >> 6283070

Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.

H O Kalkman, P B Timmermans, P A Van Zwieten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283070

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  19 in total

1.  Alpha 1 antagonistic and antiserotoninergic action during administration of ketanserin.

Authors:  J Vermylen; R Fiocchi; R Fagard; P Lijnen; J Staessen; A Amery
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

2.  Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat.

Authors:  K Gradin; T Hedner; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.

Authors:  A Gordin; P Mustajoki; R Pelkonen
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

4.  Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.

Authors:  W G Anderson; S T Kam
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

5.  Effects of ketanserin on microhemodynamics and hemorheology in patients with essential hypertension.

Authors:  M Konishi; M Sakakura; N Tsushima
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

6.  Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.

Authors:  R Fagard; R Fiocchi; P Lijnen; J Staessen; E Moerman; A de Schaepdryver; A Amery
Journal:  Br Heart J       Date:  1984-02

7.  Ketanserin in essential hypertension: effects during rest and exercise.

Authors:  B Persson; T Hedner; G Berglund
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine.

Authors:  F De Clerck; Y Somers; L Van Gorp
Journal:  Agents Actions       Date:  1984-12

9.  Effect of topical ketanserin administration on intraocular pressure.

Authors:  C Costagliola; G Iuliano; M Rinaldi; V Russo; G Scibelli; L Mastropasqua
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

10.  In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.

Authors:  S Conolan; M J Quinn; D A Taylor
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.